BAC

Bank of America Corporation

60
Fundamentals72/ 100
Valuation55/ 100
Upside potential71/ 100
Risk potential10/ 100

BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.

VMET

Versamet Royalties Corporation Common Stock

There isn't enough reported data to score VMET yet.

BAC Fundamentals

MetricStatus
Healthy
Strong
N/A
N/A

BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.

VMET Fundamentals

MetricStatus
Unavailable
Strong
N/A
N/A

VMET's profitability is currently strong. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like VMET.

BAC PE Valuation

CHEAPFAIREXPENSIVE5.6x11x17x22x
CHEAPFAIREXPENSIVE5.6x11x17x22x
LevelPEPriceVs current
Cheap9.4x$39.50-22%
Forward10x$50.51—
Current12x$50.51—
Fair13x$53.81+6.5%
Expensive15x$62.23+23%

Historical ranges are pointers, not guarantees.

BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.

VMET PE Valuation

LevelPEPriceVs current
Current9.9x$8.15—
Cheap10x$8.40+3.1%
Fair12x$9.88+21%
Expensive14x$11.26+38%
Forward23x$8.15—

Historical ranges are pointers, not guarantees.

VMET has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.

BAC Forward outlook

MetricOutlook
Improving
Growth
Growth
Strongly improving
Limited
Moderate

BAC has the edge over VMET on the outlook, with more favorable valuation and profitability expectations.

VMET Forward outlook

MetricOutlook
Strongly deteriorating
Strong growth
Strong growth
Strongly weakening
Limited
High

Analysts expect strong earnings and revenue growth for VMET, but weaker profitability.

BAC Risk to reward

ScenarioChangePrice
Upside+25%$63.36
Downside-10%$45.36

Calculated from the latest close: $50.51 on Nov 12.

There is not enough scenario data to compare BAC and VMET's risk to reward.

VMET Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $8.15 on Nov 12.

There is not enough scenario data to compare BAC and VMET's risk to reward.

BAC Earnings Per Share

Q4 2023: $3.08Q1 2024: $2.90Q2 2024: $2.85Q3 2024: $2.76Q4 2024: $3.21Q1 2025: $3.35Q2 2025: $3.41Q3 2025: $3.66Q4 2025: $3.81Q1 2026: $4.02Q2 2026: $4.34Q3 2026: $4.19Forward: $4.92
Q4 2023: $3.08Q1 2024: $2.90Q2 2024: $2.85Q3 2024: $2.76Q4 2024: $3.21Q1 2025: $3.35Q2 2025: $3.41Q3 2025: $3.66Q4 2025: $3.81Q1 2026: $4.02Q2 2026: $4.34Q3 2026: $4.19Forward: $4.92
QuarterTTM EPSYoY
Forward$4.92+17%
Q3 2026$4.19+14%
Q2 2026$4.34+27%
Q1 2026$4.02+20%
Q4 2025$3.81+19%
Q3 2025$3.66+33%
Q2 2025$3.41+20%
Q1 2025$3.35+16%
Q4 2024$3.21+4.2%

BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.

VMET Earnings Per Share

Q1 2026: $0.74Q2 2026: $0.82Forward: $0.36
Q1 2026: $0.74Q2 2026: $0.82Forward: $0.36

VMET and BAC do not have enough comparable growth data to identify a winner.

BAC Quarterly Revenue

Q4 2023: $22BQ1 2024: $25.8BQ2 2024: $25.4BQ3 2024: $25.3BQ4 2024: $25.3BQ1 2025: $27.4BQ2 2025: $26.5BQ3 2025: $28.1BQ4 2025: $31.2BQ1 2026: $30.3BQ2 2026: $31.6BQ3 2026: $30B
Q4 2023: $22BQ1 2024: $25.8BQ2 2024: $25.4BQ3 2024: $25.3BQ4 2024: $25.3BQ1 2025: $27.4BQ2 2025: $26.5BQ3 2025: $28.1BQ4 2025: $31.2BQ1 2026: $30.3BQ2 2026: $31.6BQ3 2026: $30B
QuarterRevenueYoY
Q3 2026$30B+6.7%
Q2 2026$31.6B+19%
Q1 2026$30.3B+11%
Q4 2025$31.2B+23%
Q3 2025$28.1B+11%
Q2 2025$26.5B+4.3%
Q1 2025$27.4B+6%
Q4 2024$25.3B+15%

BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.

VMET Quarterly Revenue

Q2 2025: $5MQ3 2025: $8MQ4 2025: $18MQ1 2026: $24MQ2 2026: $23M
Q2 2025: $5MQ3 2025: $8MQ4 2025: $18MQ1 2026: $24MQ2 2026: $23M
QuarterRevenueYoY
Q2 2026$23.1M+371%

VMET has the edge over BAC in the latest year-over-year revenue comparison.

BAC Free Cash Flow

Q4 2023: $32.7BQ1 2024: −$15.5BQ2 2024: $18.1BQ3 2024: −$37.3BQ4 2024: $25.9BQ1 2025: −$2.2BQ2 2025: −$9.1BQ3 2025: $46.9BQ4 2025: −$22.9BQ1 2026: $41.8BQ2 2026: $29BQ3 2026: −$6.5B
Q4 2023: $32.7BQ1 2024: −$15.5BQ2 2024: $18.1BQ3 2024: −$37.3BQ4 2024: $25.9BQ1 2025: −$2.2BQ2 2025: −$9.1BQ3 2025: $46.9BQ4 2025: −$22.9BQ1 2026: $41.8BQ2 2026: $29BQ3 2026: −$6.5B
QuarterFree cash flowYoY
Q3 2026-$6.5B-114%
Q2 2026$29B+$38.2B
Q1 2026$41.8B+$44B
Q4 2025-$22.9B-189%
Q3 2025$46.9B+$84.2B
Q2 2025-$9.1B-150%
Q1 2025-$2.2B+$13.4B
Q4 2024$25.9B-21%

BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.

VMET Free Cash Flow

Q2 2025: $2MQ3 2025: −$121MQ4 2025: $7MQ1 2026: $13MQ2 2026: $14M
Q2 2025: $2MQ3 2025: −$121MQ4 2025: $7MQ1 2026: $13MQ2 2026: $14M
QuarterFree cash flowYoY
Q2 2026$14M+508%

VMET has the edge over BAC in the latest year-over-year cash flow comparison.

BAC Total Shares

Q4 2023: 8.1BQ1 2024: 8BQ2 2024: 8BQ3 2024: 7.9BQ4 2024: 7.9BQ1 2025: 7.8BQ2 2025: 7.7BQ3 2025: 7.6BQ4 2025: 7.7BQ1 2026: 7.4BQ2 2026: 7.3BQ3 2026: 7.2B
Q4 2023: 8.1BQ1 2024: 8BQ2 2024: 8BQ3 2024: 7.9BQ4 2024: 7.9BQ1 2025: 7.8BQ2 2025: 7.7BQ3 2025: 7.6BQ4 2025: 7.7BQ1 2026: 7.4BQ2 2026: 7.3BQ3 2026: 7.2B
PeriodChange %Net change
Quarterly-1%-72M shares
1 year-5.3%-405M shares
3 years-11%-854M shares
5 years-15%-1.3B shares
Available history-24%-2.2B shares

BAC has the edge over VMET on shareholder dilution, with a more favorable share count trend.

VMET Total Shares

Q2 2025: 17MQ3 2025: 96MQ4 2025: 36MQ1 2026: 49MQ2 2026: 52M
Q2 2025: 17MQ3 2025: 96MQ4 2025: 36MQ1 2026: 49MQ2 2026: 52M
PeriodChange %Net change
Quarterly+6.5%+3.2M shares
1 year+199%+34.5M shares

VMET has 52M diluted shares, up 199% from a year ago.

BAC Net Leverage

Q4 2023: 9.5xQ1 2024: 9.5xQ2 2024: 9.4xQ3 2024: 9.9xQ4 2024: 9.0xQ1 2025: 8.6xQ2 2025: 8.8xQ3 2025: 8.3xQ4 2025: 7.7xQ1 2026: 7.1xQ2 2026: 6.7xQ3 2026: 6.4x
Q4 2023: 9.5xQ1 2024: 9.5xQ2 2024: 9.4xQ3 2024: 9.9xQ4 2024: 9.0xQ1 2025: 8.6xQ2 2025: 8.8xQ3 2025: 8.3xQ4 2025: 7.7xQ1 2026: 7.1xQ2 2026: 6.7xQ3 2026: 6.4x
QuarterNet LeverageStatus
Q3 20266.4xHigh
Q2 20266.7xHigh
Q1 20267.1xHigh
Q4 20257.7xHigh
Q3 20258.3xHigh
Q2 20258.8xHigh
Q1 20258.6xHigh
Q4 20249.0xHigh

BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.

VMET Net Leverage

Q1 2026: 0.8xQ2 2026: 5.5x
Q1 2026: 0.8xQ2 2026: 5.5x
QuarterNet LeverageStatus
Q2 20265.5xHigh
Q1 20260.8xVery low

VMET has the edge over BAC on leverage, with a lower net debt burden relative to earnings.

BAC Weekly Momentum

MetricValueStatus
RSI37.1Neutral
Stochastic4.9Oversold

BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).

VMET Weekly Momentum

MetricValueStatus
RSI39.2Neutral
Stochastic19.3Oversold

VMET's weekly RSI is 39 (neutral) and its Stochastic is 19 (oversold).

BAC PE vs Financial Services Sector

MetricBACSector medianRelative
PE12x13x7.5% below
PE %406323 pts below

BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.

VMET PE vs Financial Services Sector

MetricVMETSector medianRelative
PE9.9x13x24% below

VMET has the edge over BAC on valuation relative to its sector.

BAC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$52.13% below
20 week MA$57.813% below
50 week MA$54.77.7% below
100 week MA$50.50% below
200 week MA$42.519% above

BAC has stronger trend alignment. BAC is above 1 of 5 weekly averages versus VMET above 0 of 2.

VMET Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$8.595.1% below
20 week MA$9.3613% below

VMET is in a downtrend: it's below all two of its weekly moving averages, and 13% below its 20-week average.

BAC Yearly ROI

YearStart priceEnd priceROI
2020$35.4$30.0-15%
2021$30.0$44.4+48%
2022$44.4$32.5-27%
2023$32.5$33.7+3.7%
2024$33.7$44.3+32%
2025$44.3$56.2+27%
2026 YTD$56.2$50.5-10%

BAC has the edge over VMET on returns for 2026, with the stronger performance.

VMET Yearly ROI

YearStart priceEnd priceROI
2026 YTD$10.6$8.15-23%

It's down 23% so far in 2026.

Give your agent the market.

Get API key